Clinical Orthopaedics and Related Research®

, Volume 471, Issue 8, pp 2684–2690

Malignant Lymphoma of Bone: A Review of 119 Patients

  • Emre Demircay
  • Francis John HornicekJr
  • Henry J. Mankin
  • Henry DegrootIII
Clinical Research

Abstract

Background

Lymphoma of bone is uncommon. As a result of this, many aspects of primary lymphoma of bone (PLB) are controversial: the definition, treatment strategies, response criteria, and prognostic factors.

Questions/purposes

We sought to determine the following in an analysis from a single center over a four-decade period: (1) 5-year disease-free survival of patients with PLB as well as those with systemic lymphoma with bone involvement; and (2) whether prognostic factors (sex, site of tumor, age) were associated with 5-year survival.

Methods

A total of 119 patients with lymphoma involving the musculoskeletal system were retrospectively evaluated. Among these, 94 patients who had a minimum followup of 6 months (mean, 67 months; range, 6 months to 34 years) were further analyzed for the skeletal site of involvement, the orthopaedic intervention(s) needed, and survival. The overall median age was 45 years (range, 7–87 years). The female-to-male ratio was 1:1.53. There were 70 (65 unifocal, five multifocal) patients with PLB. The femur was the most frequent site involved. Appendicular skeleton involvement was substantially higher in patients with PLB. Thirty-four (36%) patients had at least one surgical intervention. Fourteen patients (41%) needed more than one major surgical intervention.

Results

The disease-free 5-year survival for patients with PLB was 81% and for the patients with systemic lymphoma with bone involvement, it was 44%. The disease-free 5-year survival of the patients with PLB younger than 60 years old and 60 years old or older was 90% and 62%, respectively. Age was the only prognostic factor on survival of patients with PLB.

Conclusions

Orthopaedic intervention was usually needed for pathologic fractures, avascular necrosis, spinal cord compression, or for the lesions of the weightbearing bones compromising stability or joint motion. The potential for long-term survival suggests the use of implants and techniques that have the best chance of long-term success.

Level of Evidence

Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

References

  1. 1.
    Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer. 2006;106:2652–2656.PubMedCrossRefGoogle Scholar
  2. 2.
    Christie DR, Barton MB, Bryant G, Cheuk R, Gebski V, Hornsey J, Lonergan D, MacLeod C, Pratt G, Roos D, Shannon J, Thornton D, Wirth A. Osteolymphoma (primary bone lymphoma): an Australian review of 70 cases. Australasian Radiation Oncology Lymphoma Group (AROLG). Aust N Z J Med. 1999;2:214–219.CrossRefGoogle Scholar
  3. 3.
    de Camargo OP, dos Santos Machado TM, Croci AT, de Oliveira CR, Giannotti MA, Baptista AM, Caiero MT, Alves VA, Matsumoto LA. Primary bone lymphoma in 24 patients treated between 1955 and 1999. Clin Orthop Relat Res. 2002;397:271–280.Google Scholar
  4. 4.
    de Leval L, Braaten KM, Ancukiewicz M, Kiggundu E, Delaney T, Mankin HJ, Harris NL. Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol. 2003;27:1269–1277.PubMedCrossRefGoogle Scholar
  5. 5.
    Dosoretz DE, Raymond AK, Murphy GF, Doppke KP, Schiller AL, Wang CC, Suit HD. Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer. 1982;5:1009–1014.CrossRefGoogle Scholar
  6. 6.
    Ford DR, Wilson D, Sothi S, Grimer R, Spooner D. Primary bone lymphoma—treatment and outcome. Clin Oncol (R Coll Radiol). 2007;1:50–55.CrossRefGoogle Scholar
  7. 7.
    Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, Kluin PM. Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 1999;12:2094–2098.Google Scholar
  8. 8.
    Horsman JM, Thomas J, Hough R, Hancock BW. Primary bone lymphoma: a retrospective analysis. Int J Oncol. 2006;6:1571–1575.Google Scholar
  9. 9.
    Lewis VO, Primus G, Anastasi J, Doherty D, Montag AG, Peabody TD, Simon MA. Oncologic outcomes of primary lymphoma of bone in adults. Clin Orthop Relat Res. 2003;415:90–97.PubMedCrossRefGoogle Scholar
  10. 10.
    Mulligan ME, McRae GA, Murphey MD. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol. 1999;6:1691–1697.CrossRefGoogle Scholar
  11. 11.
    Ostrowski ML, Unni KK, Banks PM, Shives TC, Evans RG, O’Connell MJ, Taylor WF. Malignant lymphoma of bone. Cancer. 1986;58:2646–2655.PubMedCrossRefGoogle Scholar
  12. 12.
    Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007;1:129–135.Google Scholar
  13. 13.
    Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Clark RM. Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group. Br J Cancer. 1992;66:603–606.PubMedCrossRefGoogle Scholar
  14. 14.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.Google Scholar
  15. 15.
    Tong M, Yau TK, Wu WC, Lam JJ, Lee AWM. Primary non-Hodgkin’s lymphoma of bone: a rare cause of lytic bone lesion. J HK Coll Radiol. 2004;7:24–30.Google Scholar
  16. 16.
    Ueda T, Aozasa K, Ohsawa M, Yoshikawa H, Uchida A, Ono K, Matsumoto K. Malignant lymphomas of bone in Japan. Cancer. 1989;11:2387–2392.CrossRefGoogle Scholar
  17. 17.
    Unni KK, Hogendoorn PCW. Malignant lymphoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:299–301. Google Scholar
  18. 18.
    Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M, Stefoni V, Sabattini E, Alinari L, Binazzi R, Tura S, Baccarani M, Pileri SA. Primary bone lymphoma: experience with 52 patients. Haematologica. 2003;3:280–285.Google Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2013

Authors and Affiliations

  • Emre Demircay
    • 1
  • Francis John HornicekJr
    • 2
  • Henry J. Mankin
    • 3
  • Henry DegrootIII
    • 4
  1. 1.Department of Orthopedic SurgeryBaskent University School of MedicineIstanbulTurkey
  2. 2.Harvard Medical School, Orthopaedic Oncology, Massachusetts General HospitalBostonUSA
  3. 3.Harvard Medical SchoolBostonUSA
  4. 4.Newton-Wellesley HospitalNewton Lower FallsUSA

Personalised recommendations